SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-22-000104
Filing Date
2022-11-03
Accepted
2022-11-03 16:03:28
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20220930.htm   iXBRL 10-Q 1133083
2 EX-10.1 exhibit101-incyte3rdamend.htm EX-10.1 19430
3 EX-31.1 exhibit31-1q32022.htm EX-31.1 9174
4 EX-31.2 exhibit31-2q32022.htm EX-31.2 9176
5 EX-32.1 exhibit32-1q32022.htm EX-32.1 4104
6 EX-32.2 exhibit32-2q32022.htm EX-32.2 3939
  Complete submission text file 0001125345-22-000104.txt   5059291

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20220930.xsd EX-101.SCH 33633
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20220930_cal.xml EX-101.CAL 41644
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20220930_def.xml EX-101.DEF 195167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20220930_lab.xml EX-101.LAB 442937
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20220930_pre.xml EX-101.PRE 312479
47 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20220930_htm.xml XML 768559
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 221357853
SIC: 2834 Pharmaceutical Preparations